Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Spire Global
SPIR
$499M
| $542K | ﹤0.01% |
66,994
| – | – |
|
|
FLNA
3052
Filana Therapeutics
FLNA
$46.4M
| $542K | ﹤0.01% |
361,253
+41,511
| +13% | +$105K |
|
|
NOTE
3053
DELISTED
FiscalNote
NOTE
| $541K | ﹤0.01% |
55,838
+8,259
| +17% | +$124K |
|
|
BLFY
3054
DELISTED
Blue Foundry Bancorp
BLFY
| $539K | ﹤0.01% |
58,601
+134
| +0.2% | +$1.28K |
|
|
AIRJ
3055
Montana Technologies Corp
AIRJ
$431M
| $537K | ﹤0.01% |
116,439
-3,780
| -3% | -$29.5K |
|
3056
Sight Sciences
SGHT
$302M
| $537K | ﹤0.01% |
223,651
-44,599
| -17% | -$126K |
|
3057
Crawford & Co Class A
CRD.A
$629M
| $535K | ﹤0.01% |
46,817
+2
| +0% | +$23 |
|
3058
Cardiff Oncology
CRDF
$74.3M
| $534K | ﹤0.01% |
169,974
+68,310
| +67% | +$270K |
|
3059
Ring Energy
REI
$312M
| $534K | ﹤0.01% |
464,030
+310
| +0.1% | +$404 |
|
3060
Foster
FSTR
$438M
| $532K | ﹤0.01% |
27,030
| – | – |
|
|
FVR
3061
FrontView REIT
FVR
$471M
| $532K | ﹤0.01% |
41,579
+8
| +0% | +$131 |
|
3062
Lexicon Pharmaceuticals
LXRX
$1.09B
| $530K | ﹤0.01% |
1,150,771
-40,320
| -3% | -$25.4K |
|
3063
LCNB Corp
LCNB
$281M
| $530K | ﹤0.01% |
35,803
+1,000
| +3% | +$15K |
|
3064
Safe Bulkers
SB
$778M
| $529K | ﹤0.01% |
143,454
+531
| +0.4% | +$1.94K |
|
|
PVBC
3065
DELISTED
Provident Bancorp
PVBC
| $526K | ﹤0.01% |
45,831
-101
| -0.2% | -$1.18K |
|
3066
Inogen
INGN
$178M
| $526K | ﹤0.01% |
73,726
| – | – |
|
3067
Pliant Therapeutics
PLRX
$65M
| $526K | ﹤0.01% |
389,349
-70,035
| -15% | -$425K |
|
3068
ThredUp
TDUP
$810M
| $526K | ﹤0.01% |
218,069
| – | – |
|
3069
Karat Packaging
KRT
$845M
| $526K | ﹤0.01% |
19,771
+51
| +0.3% | +$1.52K |
|
3070
iShares S&P Small-Cap 600 Value ETF
IJS
$8.32B
| $525K | ﹤0.01% |
5,386
-40
| -0.7% | -$4.22K |
|
3071
Avita Medical
RCEL
$138M
| $523K | ﹤0.01% |
64,215
-6,690
| -9% | -$62.5K |
|
3072
Dakota Gold
DC
$718M
| $517K | ﹤0.01% |
194,983
+238
| +0.1% | +$653 |
|
|
VTYX
3073
DELISTED
Ventyx Biosciences
VTYX
| $516K | ﹤0.01% |
448,345
-40,372
| -8% | -$69.3K |
|
3074
Flexsteel Industries
FLXS
$315M
| $515K | ﹤0.01% |
14,112
+3
| +0% | +$140 |
|
3075
FVCBankcorp
FVCB
$342M
| $513K | ﹤0.01% |
48,537
| – | – |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.